Pnc Financial Services Group, Inc. Vor Biopharma Inc. Transaction History

Pnc Financial Services Group, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$11.32 - $18.02 $22,640 - $36,040	-2,000 Closed	0 $0
Q3 2021 Nov 05, 2021	BUY	$12.24 - $20.38 $12,240 - $20,380	1,000 Added 100.0%	2,000 $31,000
Q2 2021 Aug 06, 2021	BUY	$18.65 - $38.78 $18,650 - $38,780	1,000 New	1,000 $18,000

48.4M

757K

110K

Ticker VOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,056,300
Market Cap $383M
Description
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.